https://www.selleckchem.com/pr....oducts/poziotinib-hm
7months for AM patients, and 3.0 and 20.1months for MM patients, respectively. Elevated serum lactate dehydrogenase (LDH) (AM hazard ratio [HR], 0.22; 95% confidence interval [CI], 0.06-0.87; p=0.03, MM HR, 0.20; 95% CI, 0.08-0.53; p=0.001) was significantly associated with shorter OS for both subtypes. The ORR, PFS, and OS with anti-PD-1 therapy were poor in patients with AM and MM compared to those previously reported clinical trials for nonacral CM. High serum LDH was associated with significantly shorter OS. The ORR, PF
Like
Comment
Share
